Inhibitor Therapeutics INTI
OTC INTI
$0.10 +0.00 (+0.00%)
At close: Oct 1, 2026 · 4:00 PM EDT

Inhibitor Therapeutics (INTI) Other Non Operating Income (2013)

Updated

Inhibitor Therapeutics' Other Non Operating Income was $30,000 in Q2 2013, unchanged from the prior quarter.

Analysis

Inhibitor Therapeutics (INTI) Other Non Operating Income (2013) Analysis & Trends

For FY2012, Other Non Operating Income at Inhibitor Therapeutics came in at $666,667.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Inhibitor Therapeutics 17.38 Mn 17.38 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2013 30,000.00
Mar 31, 2013 30,000.00
API Access

Inhibitor Therapeutics Other Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=INTI&period=max&api_key=YOUR_API_KEY